Humana Inc. (NYSE:HUM) Stock Position Lifted by BI Asset Management Fondsmaeglerselskab A S

BI Asset Management Fondsmaeglerselskab A S grew its position in Humana Inc. (NYSE:HUM - Free Report) by 95.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,400 shares of the insurance provider's stock after acquiring an additional 2,636 shares during the period. BI Asset Management Fondsmaeglerselskab A S's holdings in Humana were worth $1,370,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. FPC Investment Advisory Inc. purchased a new stake in shares of Humana in the 4th quarter worth about $27,000. Centricity Wealth Management LLC acquired a new stake in shares of Humana in the fourth quarter valued at approximately $30,000. LFA Lugano Financial Advisors SA increased its stake in shares of Humana by 56.3% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after purchasing an additional 45 shares in the last quarter. OFI Invest Asset Management acquired a new position in shares of Humana during the 4th quarter worth approximately $33,000. Finally, Atwood & Palmer Inc. raised its holdings in shares of Humana by 64.5% in the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock worth $39,000 after acquiring an additional 60 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Truist Financial boosted their target price on shares of Humana from $290.00 to $325.00 and gave the company a "hold" rating in a research note on Friday, April 11th. Barclays boosted their price target on Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a report on Friday, April 11th. Mizuho upped their target price on Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Royal Bank of Canada restated an "outperform" rating and issued a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. Finally, Cantor Fitzgerald reaffirmed a "neutral" rating and set a $290.00 price target on shares of Humana in a research note on Wednesday, February 12th. Seventeen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, Humana has an average rating of "Hold" and an average price target of $284.90.

Humana Stock Performance

NYSE:HUM traded down $3.91 during trading hours on Friday, reaching $263.92. 1,097,942 shares of the stock were exchanged, compared to its average volume of 1,745,084. The stock has a market capitalization of $31.85 billion, a P/E ratio of 26.52, a P/E/G ratio of 2.05 and a beta of 0.62. The firm has a 50 day simple moving average of $266.35 and a 200-day simple moving average of $270.50. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, sell-side analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, June 27th. This represents a $3.54 annualized dividend and a yield of 1.34%. Humana's payout ratio is 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.